<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-154399" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Oxygenation Status and Pulse Oximeter Analysis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Pesola</surname>
            <given-names>Gene R.</given-names>
          </name>
          <aff>Harlem Hospital/Columbia University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sankari</surname>
            <given-names>Abdulghani</given-names>
          </name>
          <aff>Wayne State University</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Gene Pesola declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Abdulghani Sankari declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>11</day>
          <month>6</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-154399.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Healthcare practitioners must possess crucial skills in assessing the oxygenation status of individuals through the alveolar-arteriole oxygenation gradient (A-a gradient). Understanding the normal and abnormal range of the gradient, its interpretation, and its clinical utility are essential. Differentiating between hypoxemia and hypoxia is vital, as is recognizing the 4 common causes of hypoxia. This activity provides an overview of pulse oximetry, a widely used noninvasive method for assessing oxygenation. This activity reviews pulse oximeters' functioning, ubiquity, and ability to supply oxygenation information.
Additionally, the discussion includes co-oximeters, which differ from pulse oximeters and offer insights into functional and fractional saturation and the detection of dyshemoglobinemias. Addressing complex oxygenation problems requires the collaborative efforts of multidisciplinary teams, including pulmonary practitioners, critical care specialists, anesthesiology professionals, radiologists, and pathologists, when necessary. These healthcare professionals can effectively evaluate, diagnose, and treat patients with oxygenation-related challenges by working together.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Assess and interpret pulse oximeter readings, considering factors such as patient age, skin pigmentation, peripheral perfusion, and potential interference.</p></list-item><list-item><p>Differentiate between arterial hypoxemia and hypoxia to accurately interpret oxygenation status and guide appropriate interventions.</p></list-item><list-item><p>Select appropriate interventions based on pulse oximeter findings, such as administering supplemental oxygen or initiating further diagnostic investigations.</p></list-item><list-item><p>Transition to co-oximetry when pulse oximetry is ineffective.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=154399&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=154399">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-154399.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Healthcare providers must comprehensively understand oxygenation, which involves calculating the Alveolar-arterial oxygen gradient (A-a gradient) and comprehending its implications for individuals and potential diseases. Differentiating between arterial hypoxemia and hypoxia and identifying associated conditions and appropriate treatments are vital skills. Additionally, the risks associated with hyperoxemia and hyperoxia will be emphasized to highlight the potential harm caused by excessive oxygen administration.</p>
        <p>The activity will also provide an overview of the&#x000a0;3 common dyshemoglobinemias, with a particular focus on carbon monoxide poisoning, a condition frequently encountered in clinical settings. Furthermore, participants will learn about pulse oximeters, including their purpose and how they differ from co-oximeters, enabling healthcare providers to make informed decisions regarding oxygenation monitoring.</p>
        <p>By engaging in this activity, healthcare providers can enhance their competency in understanding and managing oxygenation-related issues, enabling them to deliver optimal care and improve patient outcomes.</p>
      </sec>
      <sec id="article-154399.s3" sec-type="Function">
        <title>Function</title>
        <p>
<bold>Definitions Generally Used</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Oxygen saturation: The proportion of hemoglobin inside red blood cells that can bind oxygen. This generally means functional hemoglobin or functional arterial oxygen saturation.</p>
          </list-item>
          <list-item>
            <p>SaO<sub>2</sub> is arterial saturation measured by ABG. This entity excludes certain dyshemoglobinemia and only includes effective hemoglobins. SaO<sub>2</sub> is expressed as 100% X (O2Hb)/(O2Hb + Hb).&#x000a0;</p>
          </list-item>
          <list-item>
            <p>SpO<sub>2</sub> is&#x000a0;oxygen saturation measured by pulse oximetry using light wavelength. Commercially available oximeters use&#x000a0;2 light-emitting diodes (LEDs) that emit light at the&#x000a0;660 nm (red) and the 940 nm (infrared) wavelengths.<xref ref-type="bibr" rid="article-154399.r1">[1]</xref></p>
          </list-item>
          <list-item>
            <p>The pressure of any inspired gas (P gas) is equal to the partial pressure of the gas times the barometric pressure. The normal partial pressure of oxygen at sea level is simply the fractional inspired of oxygen (FiO<sub>2</sub>) (0.21) times the barometric pressure (760 mm Hg at sea level), which is 160 mm Hg or 159 (if one uses 0.2093 as the FiO<sub>2</sub>).</p>
          </list-item>
          <list-item>
            <p>The A-a gradient (or difference)&#x000a0;is defined as the alveolar oxygen content minus the arterial oxygen content obtained from an arterial blood gas (ABG). Theoretically, there should be no gradient, but in reality, there is at least a 5 mm Hg or more gradient. The alveolar oxygen content comes from at least 300&#x000a0;to 400 million or more alveoli present at birth&#x000a0;and tends to be a calculated value.<xref ref-type="bibr" rid="article-154399.r2">[2]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Alveolar oxygen&#x000a0;tension (PAO2)</bold>
</p>
        <p>It is essential to understand how the alveolar oxygen equation is developed.&#x000a0;</p>
        <p>PAO<sub>2</sub> = (Patm &#x02013; PH20) FiO2 &#x02013; PaCO<sub>2</sub>/RQ where Patm&#x000a0;is atmospheric pressure and RQ is the respiratory quotient.&#x000a0;</p>
        <p>Patm is equal to 760 torrs at sea level, and the PH<sub>2</sub>O is the partial pressure of water vapor pressure in humans of 47 mmHg at body temperature (37 degrees Celcius). The room air FiO<sub>2</sub> is 0.21. The respiratory quotient (RQ) varies from 0.707 to 1.0 and is usually estimated as 0.80 for an average diet (that includes carbohydrates, protein, and fat).&#x000a0;</p>
        <p>Based on these assumptions, the following calculation is made:</p>
        <p>PAO<sub>2</sub> = (760 mm Hg &#x02013; 47 mm Hg) 0.21 &#x02013; 40 mm Hg/0.8 = 150 mm Hg &#x02013; 50 mm Hg = 100 mm Hg. Therefore at sea level on room air, the only variables that should change to get the PAO<sub>2</sub> or alveolar oxygen are the arterial PaCO2 and the RQ. Assuming an RQ of 0.8 (volume of CO<sub>2</sub> released/volume of O<sub>2</sub> consumed) means the PaCO<sub>2</sub> is the only variable that changes. The common exceptions would be at high altitudes and hypoventilation, where the PA0<sub>2</sub> decreases.</p>
        <p>
<bold>Arterial Oxygen Tension (PaO2)</bold>
</p>
        <p>PaO<sub>2</sub> refers to the small amount of oxygen dissolved in the plasma after it diffuses from the alveolar spaces in the lung. PaO<sub>2</sub> is usually&#x000a0;obtained from an&#x000a0;arterial blood sample. The PaO2&#x000a0;measurement&#x000a0;is useful, especially when&#x000a0;false values of SpO<sub>2</sub> are suspected (such as in dark skin, dyshemoglobinemia, or severe anemia).</p>
        <p>&#x000a0;<bold>Alveolar-Arterial Oxygen Gradient or (A-a) Gradient</bold></p>
        <p>The difference between the PA0<sub>2</sub> and&#x000a0;PaO<sub>2</sub>&#x000a0;is known as the alveolar-arterial oxygen gradient. This varies from about 5 to 25 mm Hg. It is calculated as the PAO<sub>2</sub> (100 mm Hg) &#x02013;&#x000a0;PaO<sub>2</sub> (approximately 95 mm Hg in a healthy&#x000a0;young and nonsmoking person)&#x000a0;equals 5 mm Hg. Therefore, the A &#x02013; a difference (or A-a gradient) on room air last sea level is calculated as follows:</p>
        <p>PAO<sub>2</sub> [(760 mm Hg&#x02013; 47 mm Hg) 0.21 &#x02013; 40 mm Hg/0.8 = 150 mm Hg &#x02013; 50 mm Hg] &#x02013; PaO<sub>2</sub> (95 mmHg) = 5 mm Hg (or more with age).&#x000a0;</p>
        <p>For older individuals, there are formulas to adjust for age to calculate the A-a difference, such as [A-a difference adjusted for age= A-a difference (age/4) + 4].<xref ref-type="bibr" rid="article-154399.r3">[3]</xref></p>
        <p>A normal PA0<sub>2</sub> is about 100 mm Hg, with the arterial Pa0<sub>2</sub> varying from about 95 mm Hg to as low as 75 mm Hg (or lower, depending on who one talks to). It is well known that the arterial PaO<sub>2</sub> in mm Hg on room air decreases with age.<xref ref-type="bibr" rid="article-154399.r4">[4]</xref>&#x000a0;A crucial point to remember is that an ABG saturation is about 100% when the ABG partial pressure of oxygen is approximately 97 mm Hg or more (depends a little on the oxygen dissociation curve). This means that once the ABG saturation is 100%, the partial pressure of oxygen could be 100, 200, 300, 400, 500 mm Hg or more.</p>
        <p>If on room air, the difference is probably closer to 100 mmHg. Also, once the saturation is 100%, all&#x000a0;4 oxygens on each hemoglobin molecule have one oxygen and are full. Therefore, the only way to further increase oxygen transport is to increase hemoglobin.&#x000a0;</p>
        <p>Also, if the A-a gradient is calculated with inspired oxygen greater than room air, the alveolar PA0<sub>2</sub> will increase faster than the arterial PaO<sub>2</sub> resulting in an increasing A-a gradient. This is normal. Another point is that the A-a gradient on room air can increase faster with disease (and not just age). This is important to remember.&#x000a0;</p>
        <p>
<bold>Arterial Hyperoxia</bold>
</p>
        <p>Arterial hyperoxemia refers to a high PaO2&#x000a0;in arterial blood.<xref ref-type="bibr" rid="article-154399.r5">[5]</xref>&#x000a0;This is defined as a PaO2&#x000a0;of 100 to 300 mm Hg or a PaO<sub>2</sub> of &#x0003e;300 mm Hg post-cardiopulmonary arrest.<xref ref-type="bibr" rid="article-154399.r5">[5]</xref>&#x000a0;A high PaO<sub>2</sub> is now considered risky in acute myocardial infarction, as noted in the DETOX-AMI trial (Hofmann et al) and others.<xref ref-type="bibr" rid="article-154399.r6">[6]</xref><xref ref-type="bibr" rid="article-154399.r7">[7]</xref>&#x000a0;Treating patients without hypoxemia (a pulse oximeter saturation &#x0003c;90%) during acute ischemia and a possible myocardial infarction is now considered reasonable.<xref ref-type="bibr" rid="article-154399.r6">[6]</xref><xref ref-type="bibr" rid="article-154399.r7">[7]</xref></p>
        <p>
<bold>Arterial Hypoxia</bold>
</p>
        <p>Hypoxia is where oxygen at the tissue and organ level is unavailable to provide adequate homeostasis.<xref ref-type="bibr" rid="article-154399.r8">[8]</xref><xref ref-type="bibr" rid="article-154399.r9">[9]</xref>&#x000a0;Arterial hypoxemia refers to a decrease in the PaO<sub>2</sub> in arterial blood. An actual value is a PaO2 &#x0003c;60 mm Hg on pulse oximetry or an ABG saturation &#x0003c;90%. The ABG is still the gold standard because pulse oximeters can read up to 2 mm Hg above or below the true value.</p>
        <p>Arterial hypoxia symptoms include anxiety, confusion, tachypnea, and dyspnea. Chronic low oxygen, particularly with cancer, results in hypoxia-inducible factor (HIF) cell synthesis, which allows oxygen-deprived cells to survive and proliferate. When there is no hypoxia, von Hippel-Lindau (VHL) changes and binds to HIF, which is degraded.</p>
        <p>VHL does not change when hypoxia is present, and HIF is not changed. Hypoxia treatment includes exogenous oxygen to return to normal levels, then treating the underlying disease. All causes of hypoxia can cause cell death, or there can be recovery. There are at least&#x000a0;4 common causes of hypoxia which are:</p>
        <list list-type="bullet">
          <list-item>
            <p>Hypoxemic hypoxia: Hypoxemia is present and may cause weakness and fatigue; it is the most common cause of hypoxia. Oxygen therapy and treatment of the underlying disease are the treatments of choice.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Anemic hypoxia: This is due to either low hemoglobin or deshemoglobminemia (methemoglobinemia, sulfhemoglobinemia, and carboxyhemoglobinemia) (functional anemia).<xref ref-type="bibr" rid="article-154399.r10">[10]</xref> One needs to fix the dyshemoglobinemia or transfuse blood to resolve the problem.&#x000a0;</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Histotoxic hypoxia (reduced oxygen-carrying capacity): The inability to use available oxygen due to cyanide toxicity.<xref ref-type="bibr" rid="article-154399.r11">[11]</xref>&#x000a0;Cyanide toxicity is often due to fires in the U.S. Toxic levels of cyanide were seen in the past from sodium nitroprusside used intravenously for hypertensive emergencies. Sodium nitroprusside has 5 cyanide groups per molecule, halting cellular respiration by blocking oxygen from going to water. Cyanide toxicity&#x000a0;can lead to the failure of the&#x000a0;tissue&#x000a0;to use oxygen; however, despite&#x000a0;that, the pulse oximeter reading is usually within normal due to the standard binding capacity of oxygen to hemoglobin.<xref ref-type="bibr" rid="article-154399.r11">[11]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Circulatory hypoxia (stagnant hypoxia) or ischemic hypoxia: Heart failure is often a problem. In this instance, one needs to treat the underlying cause&#x000a0;of heart failure.<xref ref-type="bibr" rid="article-154399.r8">[8]</xref><xref ref-type="bibr" rid="article-154399.r9">[9]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Other mechanisms of hypoxia: Increased O<sub>2</sub> extraction or pseudo hypoxemia (due to hyperleukocytosis in patients with hematological&#x000a0;malignancies&#x000a0;who are susceptible to acquired infections).<xref ref-type="bibr" rid="article-154399.r12">[12]</xref><xref ref-type="bibr" rid="article-154399.r13">[13]</xref>&#x000a0;</p>
          </list-item>
        </list>
        <p>
<bold>Oxyhemoglobin Dissociation Curve (ODC) and Oxygen-Myoglobin Dissociation Curve and Binding</bold>
</p>
        <p>Oxygen in blood is transported primarily by hemoglobin; only about 2% is dissolved and follows Henry&#x02019;s Law. Usually,&#x000a0;4 oxygen molecules are bound to each hemoglobin tetramer when the molecule is completely saturated. A sigmoid shape occurs when plotting oxygen tension on the x-axis and oxygen saturation on the y-axis.</p>
        <p>The curve tends to be flat at high oxygen tensions in the pulmonary circuit because oxygen saturations are close to 100% or 100%. The curve goes from flat to much steeper at low oxygen tensions as oxygen is added to hemoglobin. With the addition of each new oxygen molecule to hemoglobin, the conformation of hemoglobin changes, which facilitates the binding of the next oxygen molecule. This property is called binding cooperativity. The p50 is when 50% of the hemoglobin molecules are bound with oxygen.</p>
        <p>A normal p50 is from 26 to 27 mm Hg. A high p50 indicates a low oxygen affinity for hemoglobin and vice versa. The high p50 also means easy delivery of oxygen to the tissues. This is seen with acidosis, elevated temperature (exercise), increased 2,3 BPG (stays high in stored blood for at least one week), and increased temperature. (see table). The converse is also true. A low p50 (high oxygen affinity for hemoglobin) is seen with CO poisoning, methemoglobin, and fetal hemoglobin. The high oxygen affinity with fetal hemoglobin allows it to take oxygen from the mother for its own use.</p>
        <table-wrap id="article-154399.table0" position="float" orientation="portrait">
          <caption>
            <title>Table. Left versus Right Shift in the Sigmoid Oxyhemoglobin Dissociation Curve</title>
          </caption>
          <table style="width: 572.604px; border-color: black;" border="1">
            <tbody>
              <tr style="height: 35px;">
                <td style="height: 35px; width: 100px;" rowspan="1" colspan="1">
<p><bold>Factor Type</bold></p>
</td>
                <td style="height: 35px; width: 141px;" rowspan="1" colspan="1">
<p><bold>Factor Change-2</bold></p>
</td>
                <td style="height: 35px; width: 142px;" rowspan="1" colspan="1">
<p><bold>Factor Change-3</bold></p>
</td>
                <td style="height: 35px; width: 164.604px;" rowspan="1" colspan="1">
<p><bold>Oxygen Avidity by factor change</bold></p>
</td>
              </tr>
              <tr style="height: 35.5px;">
                <td style="height: 35.5px; width: 100px;" rowspan="1" colspan="1">
<p>2,3 BPG</p>
</td>
                <td style="height: 35.5px; width: 141px;" rowspan="1" colspan="1">
<p>Increased, Right shift</p>
</td>
                <td style="height: 35.5px; width: 142px;" rowspan="1" colspan="1">
<p>Decreased, Left shift</p>
</td>
                <td style="height: 35.5px; width: 164.604px;" rowspan="1" colspan="1">
<p>First 2, Then 3</p>
</td>
              </tr>
              <tr style="height: 35px;">
                <td style="height: 35px; width: 100px;" rowspan="1" colspan="1">
<p>Acidity</p>
</td>
                <td style="height: 35px; width: 141px;" rowspan="1" colspan="1">
<p>Increased, Right shift</p>
</td>
                <td style="height: 35px; width: 142px;" rowspan="1" colspan="1">
<p>Decreased, Left shift</p>
</td>
                <td style="height: 35px; width: 164.604px;" rowspan="1" colspan="1">
<p>First 2, Then 3</p>
</td>
              </tr>
              <tr style="height: 35px;">
                <td style="height: 35px; width: 100px;" rowspan="1" colspan="1">
<p>pCO2</p>
</td>
                <td style="height: 35px; width: 141px;" rowspan="1" colspan="1">
<p>Increased, Right shift</p>
</td>
                <td style="height: 35px; width: 142px;" rowspan="1" colspan="1">
<p>Decreased, Left shift</p>
</td>
                <td style="height: 35px; width: 164.604px;" rowspan="1" colspan="1">
<p>First 2, Then 3</p>
</td>
              </tr>
              <tr style="height: 35px;">
                <td style="height: 35px; width: 100px;" rowspan="1" colspan="1">
<p>Temperature</p>
</td>
                <td style="height: 35px; width: 141px;" rowspan="1" colspan="1">
<p>Increased, Right shift</p>
</td>
                <td style="height: 35px; width: 142px;" rowspan="1" colspan="1">
<p>Decreased, Left shift</p>
</td>
                <td style="height: 35px; width: 164.604px;" rowspan="1" colspan="1">
<p>First 2, Then 3</p>
</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p>Myoglobin is found in skeletal muscle and has a higher affinity for oxygen than other adult hemoglobin. This entity becomes saturated at lower oxygen levels and holds onto oxygen until oxygen in the muscles is very low. The delayed release of oxygen slows the start of anaerobic metabolism and lactic acidosis. The myoglobin molecule is a single polypeptide chain, and the oxygen-myoglobin dissociation curve is logarithmic and not sigmoidal. Myoglobin is not capable of cooperative binding.</p>
        <p>CO-oximetry is also useful in rare congenital or acquired conditions responsible for dyshemoglobinemias, such as methemoglobinemia and Sulfhemoglobinemia.<xref ref-type="bibr" rid="article-154399.r14">[14]</xref><xref ref-type="bibr" rid="article-154399.r15">[15]</xref><xref ref-type="bibr" rid="article-154399.r16">[16]</xref><xref ref-type="bibr" rid="article-154399.r17">[17]</xref>&#x000a0;Many co-oximeters have only recently become capable of detecting sulfhemoglobin because it resembles methemoglobinemia and is frequently overlooked. Sulfhemoglobin is a green-pigmented molecule that often results in cyanosis. Despite physiologic anemia, sulfhemoglobinemia is generally well tolerated, possibly because it causes a right shift in the hemoglobin oxygenation dissociation curve (in contrast to the other types of dyshemoglobinemias).</p>
      </sec>
      <sec id="article-154399.s4" sec-type="Issues of Concern">
        <title>Issues of Concern</title>
        <p>
<bold>Clinical Presentation of Hypoxia</bold>
</p>
        <p>Hypoxia symptoms are nonspecific and vary depending on severity, cause, and which parts of the body are affected. When oxygen is low, the patient might feel dyspneic. However, hypoxia may be asymptomatic. Hence patients with advanced chronic respiratory conditions, such as chronic obstructive pulmonary disease (COPD), may experience symptoms with resting, exertional, and nocturnal hypoxemia which include:</p>
        <list list-type="order">
          <list-item>
            <p>Headache</p>
          </list-item>
          <list-item>
            <p>Restlessness</p>
          </list-item>
          <list-item>
            <p>Confusion</p>
          </list-item>
          <list-item>
            <p>Anxiety</p>
          </list-item>
          <list-item>
            <p>Tachycardia</p>
          </list-item>
          <list-item>
            <p>Tachypnea</p>
          </list-item>
          <list-item>
            <p>Dyspnea</p>
          </list-item>
        </list>
        <p>
<bold>Goal-directed Oxygen Therapy</bold>
</p>
        <p>Based on current evidence, it is recommended to avoid PaO<sub>2</sub> levels exceeding 300 mm Hg to mitigate potential adverse effects, including neurotoxicity and reperfusion injuries.<xref ref-type="bibr" rid="article-154399.r18">[18]</xref> Recent studies suggested that using oxygen to correct hypoxia should be gaol targeted to avoid deleterious consequences.<xref ref-type="bibr" rid="article-154399.r19">[19]</xref><xref ref-type="bibr" rid="article-154399.r20">[20]</xref>&#x000a0;</p>
        <p>A recent study by Girardis et al demonstrated that in&#x000a0;critically ill patients (with an ICU length&#x000a0;of more than 72 h), a conservative protocol for oxygen therapy (to maintain SpO<sub>2</sub> between 94&#x000a0;and 97% and median PaO<sub>2</sub>, 87mm Hg) versus conventional therapy (SpO<sub>2</sub> between 97&#x000a0;and 100% and PaO<sub>2</sub>, 102 mm Hg) resulted in lower ICU mortality. In addition, there&#x000a0;has been growing evidence that hyperoxemia could be harmful such as in patients with acute coronary syndromes and following cardio-respiratory arrests.</p>
        <p>Likewise, in patients with ARDS, oxygen administration above goal (defined&#x000a0;as PaO<sub>2</sub>&#x000a0;&#x0003e;80 mm Hg and FiO<sub>2</sub> &#x0003e;0.5) was reported to lead to&#x000a0;worse clinical outcomes at different levels of ARDS severity.<xref ref-type="bibr" rid="article-154399.r21">[21]</xref></p>
        <p>
<bold>Accuracy of SpO<sub>2</sub> in screening for eligibility for long-term O<sub>2</sub> therapy (LTOT)</bold>
</p>
        <p>Oxygen therapy is recommended for eligible patients with evidence of chronic hypoxia, such as COPD, who have moderate-to-severe hypoxia (SpO<sub>2</sub> &#x0003c;88% at rest).<xref ref-type="bibr" rid="article-154399.r22">[22]</xref>&#x000a0;However, less severe hypoxia (resting SpO<sub>2</sub> 89-93% or isolated exertional desaturation not exceeding 90%) did not improve all-cause mortality or hospitalization in patients with COPD.<xref ref-type="bibr" rid="article-154399.r23">[23]</xref></p>
        <p>The ability of SpO<sub>2</sub> to provide accurate values f oxygenation is limited to mild degrees of hypoxia as the correlation between it and PaO2 is not linear and becomes more variable with more severe hypoxia (SaO<sub>2</sub> &#x0003c;88%).<xref ref-type="bibr" rid="article-154399.r24">[24]</xref>&#x000a0;Furthermore, SpO<sub>2</sub> can lead to significant&#x000a0;misclassification in certain conditions, such as in individuals with dark skin (non-white races such as black and Asian).<xref ref-type="bibr" rid="article-154399.r25">[25]</xref>&#x000a0;The lacking precision of SpO<sub>2</sub>&#x000a0;has been reported to fail to accurately identify PaO<sub>2</sub>&#x000a0; values in the hypoxia ranges (&#x0003c;55 mm Hg) and hence the inability to adequately detect LTOT eligibility.<xref ref-type="bibr" rid="article-154399.r26">[26]</xref></p>
      </sec>
      <sec id="article-154399.s5" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>
<bold>Pulse Oximeter Analysis</bold>
</p>
        <p>This is a quick, inexpensive, portable, lightweight, noninvasive method for measuring a person&#x02019;s continuous oxygenation status and is sometimes called the fifth vital sign. In 95% of cases, this method is accurate within 4% and usually uses transmissive pulse oximetry. These instruments are 2-wavelength devices that measure only two hemoglobin types. These hemoglobin types are oxyhemoglobin and hemoglobin not bound to oxygen. These are two equations with&#x000a0;2 unknowns. The device uses 2 light-emitting&#x000a0;diodes emitting light at 660 nm (red) and 940 nm (infrared).<xref ref-type="bibr" rid="article-154399.r1">[1]</xref>&#x000a0;</p>
        <p>These&#x000a0;2 wavelengths pass through a finger, earlobe, or foot to a photodetector. The red region or oxyhemoglobin (O2Hb) absorbs less light than hemoglobin (Hb), while the reverse is true with infrared. A ratio of these two absorbances at these wavelengths is calibrated against arterial blood gas saturations from a co-oximeter in normal volunteers and is stored as a calibration algorithm. This algorithm within the device is then called up when needed, and the pulse oximeter estimates the saturation.</p>
        <p>One problem is that the normal volunteers tend to be white, and it has been shown that pulse oximeters may tend to be under-read in dark-skinned subjects.<xref ref-type="bibr" rid="article-154399.r27">[27]</xref>&#x000a0;This is partly related to proprietary issues. This same procedure needs to be&#x000a0;researched in dark-skinned individuals. Thus, this technique&#x000a0;still needs&#x000a0;validation in other populations and conditions.<xref ref-type="bibr" rid="article-154399.r28">[28]</xref></p>
        <p>The advantage of pulse oximetry is that despite being quick and noninvasive, no study has yet noted a difference in mortality.<xref ref-type="bibr" rid="article-154399.r29">[29]</xref>&#x000a0;Hypoxemia, (defined here as pulse oximeter saturation &#x0003c;90%) was 7.9% with pulse oximetry and 0.4% in those without pulse oximetry.<xref ref-type="bibr" rid="article-154399.r29">[29]</xref>&#x000a0;</p>
        <p>Eleven years later, 100% of patients undergoing bariatric surgery had hypoxemia (hypoxemia defined as a sat &#x0003c;90% for at least 30 s in this study).<xref ref-type="bibr" rid="article-154399.r30">[30]</xref> The average nadir saturation was 75 + 8 mm Hg, and the pCO<sub>2</sub> was 37 + 3 mm Hg (no hypercarbia).<xref ref-type="bibr" rid="article-154399.r30">[30]</xref>&#x000a0;Another pulse oximeter advantage is that fewer blood gases are&#x000a0;needed when oxygenation status is known. At the same time, pulse oximeter accuracy is known to be decreased with saturations below 80, hypotension, and nail polish on fingernails.<xref ref-type="bibr" rid="article-154399.r31">[31]</xref>&#x000a0;</p>
        <p>The gold standard is still the ABG which gives the best saturations. In addition, ABGs provide more information related to pH, pCO<sub>2</sub>, and acid-base status and are often needed. Despite its pros and cons, pulse oximetry has taken the nation by storm in the last 25 years and is here to stay. There are more benefits than negatives. When using pulse oximetry and co-oximetry, it is important for healthcare providers to consider the presence of certain dyshemoglobinemias, which are conditions where oxygen-binding moieties are unable to effectively bind oxygen. The&#x000a0;3 notable dyshemoglobinemias that need to be considered in this context are CO poisoning, methemoglobinemia, and, although rare, sulfhemoglobinemia.</p>
        <p>Fractional SaO<sub>2</sub> = Sometime called FO<sub>2</sub>Hb; it is the same as SaO<sub>2</sub> (functional arterial saturation) when there is no dyshemoglobinemia.</p>
        <p>When there is a dyshemoglobinemia, fractional saturation measures all hemoglobin, and the formula is 100% X (02Hb)/(02Hb + Hb + COHb + MetHb + Sulfhemoglobinemia).</p>
        <p>The partial pressure of oxygen (PaO<sub>2</sub>): The pressure of oxygen in mm Hg in the blood can be obtained with an ABG with normal values from 75 to at least 95 mm Hg.</p>
        <p>CO-oximetry requires arterial blood gas and is divided into functional and fractional oxygen saturations (SaO<sub>2</sub>). Functional SaO<sub>2</sub> includes hemoglobins that bind to oxygen.<xref ref-type="bibr" rid="article-154399.r32">[32]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Functional SaO<sub>2</sub> = (O2Hb)/(O2Hb + Hb) X 100%.&#x000a0;Normal Value: 95 &#x02013; 100%.</p>
          </list-item>
        </list>
        <p>Fractional SaO<sub>2</sub> is important because it includes all hemoglobin, ie, those that don&#x02019;t bind oxygen (methemoglobin, carboxyhemoglobin, and sulfhemoglobinemia) and those that do (02Hb and Hb) and require one equation for each hemoglobin (wavelength).<xref ref-type="bibr" rid="article-154399.r32">[32]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Fractional SaO<sub>2</sub> = (02Hb)/(02Hb + Hb + COHb + MetHb) X 100%.</p>
          </list-item>
          <list-item>
            <p>Normal Value: 94 &#x02013; 98%.</p>
          </list-item>
          <list-item>
            <p>Example 2: O2Hb = 10.0 mg/dL, Hb: 0.5 mg/dL. Methemoglobin: 2.0 mg/dL. COHb: 5 mg/dL.</p>
          </list-item>
          <list-item>
            <p>Answer: 10 mg/dL/17.5 mg/dL = 57%.</p>
          </list-item>
          <list-item>
            <p>FO<sub>2</sub>Hb = Fractional SaO<sub>2</sub>; it is lower than the regular SaO<sub>2</sub> in dyshemoglobinemia.&#x000a0;</p>
          </list-item>
        </list>
        <p>Theoretically, functional and fractional hemoglobins are identical when only O2Hb and Hb are present. When the oxygen saturation level is below or higher than expected&#x000a0;by pulse oximetry using a 2-wavelength system, consider co-oximetry to ensure no dyshemoglobinemia is present.</p>
        <p>Oxygen Content (CtO<sub>2</sub>) = SaO<sub>2</sub> X CtHb mg/dL X (1-FCOHb-FmetHg) +</p>
        <p>Pa0<sub>2</sub> X 0.003 ml 0<sub>2</sub> per gm Hg/dL</p>
        <p>Normal CtO<sub>2</sub> = 18.8 to 22.3 ml/dL -generally 2% dissolved oxygen and 98% on Hb.</p>
        <p>Normal SaO<sub>2</sub> = ct0<sub>2</sub>2Hb/ct (0<sub>2</sub>Hb + HHb) X 100% = 95 &#x02013; 100%.</p>
        <p>One can increase Oxygen Content by transfusions, reducing dyshemoglobinemias, or giving oxygen.</p>
        <p>Sa0<sub>2</sub> = percent of oxygenated hemoglobin relative to the amount of hemoglobin capable of carrying oxygen. Reference value = 95% to 100%.</p>
        <p>Using&#x000a0;2 wavelengths, simple co-oximeters will give similar functional and fractional values in&#x000a0;healthy young white individuals. Pulse oximetry estimates the saturation of hemoglobin and does not give estimates of actual Pa0<sub>2</sub> or other bound gazes, such as carbon monoxide (CO), which require different oximeters. The co-oximeter is a special spectrophotometer used to measure different oxygen saturations. This type of spectrophotometer is used to determine whether a dyshemoglobinemia is present.<xref ref-type="bibr" rid="article-154399.r15">[15]</xref><xref ref-type="bibr" rid="article-154399.r33">[33]</xref>&#x000a0;&#x000a0;</p>
        <p>
<bold>Arterial Hypoxemia -&#x000a0;5 Common Causes</bold>
</p>
        <list list-type="order">
          <list-item>
            <p>Diffusion abnormality<xref ref-type="bibr" rid="article-154399.r34">[34]</xref><xref ref-type="bibr" rid="article-154399.r35">[35]</xref><xref ref-type="bibr" rid="article-154399.r36">[36]</xref></p>
          </list-item>
        </list>
        <p>Carbon monoxide is the tracer of choice to measure diffusion since it is diffusion limited. Nitrous oxide (NO) and oxygen are perfusion limited. Oxygen can become diffusion limited if the membrane becomes thickened, particularly if the 0.75-second normal capillary time drops with exercise (can drop to as low as 0.20 seconds with exercise). One can demonstrate that the thickening of the alveolar membrane results in a diffusion capacity for oxygen of less than &#x000be; of a second. The normal diffusion (DLCO) in the 2017 guidelines is no longer specified, but a value of 0.75 predicted or greater per an older guideline would probably be considered normal.<xref ref-type="bibr" rid="article-154399.r35">[35]</xref><xref ref-type="bibr" rid="article-154399.r36">[36]</xref></p>
        <p>&#x000a0; &#x000a0; &#x000a0;2. Right to Left Shunt (normal shunt &#x0003c;5%, from Thebesian and bronchial veins).&#x000a0;</p>
        <p>The&#x000a0;5 common mechanisms of hypoxemia: order listed from common to rare.</p>
        <table-wrap id="article-154399.table1" position="float" orientation="portrait">
          <table style="width: 930px; height: 371px; border-color: black;" border="1">
            <tbody>
              <tr style="height: 96px;">
                <td style="width: 102px; height: 96px;" rowspan="1" colspan="1">
<p><bold>Hypoxemia Type</bold></p>
<p><bold>&#x000a0;</bold></p>
</td>
                <td style="width: 175px; height: 96px;" rowspan="1" colspan="1">
<p><bold>Feature</bold></p>
</td>
                <td style="width: 84.5486px; height: 96px;" rowspan="1" colspan="1">
<p><bold>A-a gradient</bold></p>
</td>
                <td style="width: 390.451px; height: 96px;" rowspan="1" colspan="1">
<p><bold>&#x000a0; 0xygen&#x000a0; response</bold></p>
</td>
                <td style="width: 141px; height: 96px;" rowspan="1" colspan="1">
<p><bold>Diseases</bold></p>
</td>
              </tr>
              <tr style="height: 59px;">
                <td style="width: 102px; height: 59px;" rowspan="1" colspan="1">
<p>1. V/Q mismatch</p>
</td>
                <td style="width: 175px; height: 59px;" rowspan="1" colspan="1">
<p>Normal V/Q ratio&#x000a0;(0.80)</p>
<p><bold>&#x000a0;</bold></p>
</td>
                <td style="width: 84.5486px; height: 59px;" rowspan="1" colspan="1">
<p>Elevated</p>
</td>
                <td style="width: 390.451px; height: 59px;" rowspan="1" colspan="1">
<p>&#x000a0;Good</p>
</td>
                <td style="width: 141px; height: 59px;" rowspan="1" colspan="1">
<p>Asthma, COPD</p>
</td>
              </tr>
              <tr style="height: 72px;">
                <td style="width: 102px; height: 72px;" rowspan="1" colspan="1">
<p>2. Decreased &#x000a0;&#x000a0;&#x000a0;&#x000a0; ventilation</p>
</td>
                <td style="width: 175px; height: 72px;" rowspan="1" colspan="1">
<p>Elevated PaCO2</p>
</td>
                <td style="width: 84.5486px; height: 72px;" rowspan="1" colspan="1">
<p>Normal</p>
</td>
                <td style="width: 390.451px; height: 72px;" rowspan="1" colspan="1">
<p>&#x000a0;Good</p>
</td>
                <td style="width: 141px; height: 72px;" rowspan="1" colspan="1">
<p>Obesity, drug overdose.</p>
</td>
              </tr>
              <tr style="height: 35px;">
                <td style="width: 102px; height: 35px;" rowspan="1" colspan="1">
<p>3. Shunt</p>
</td>
                <td style="width: 175px; height: 35px;" rowspan="1" colspan="1">
<p>&#x0003c;5% is normal.&#x000a0;</p>
</td>
                <td style="width: 84.5486px; height: 35px;" rowspan="1" colspan="1">
<p>Elevated</p>
</td>
                <td style="width: 390.451px; height: 35px;" rowspan="1" colspan="1">
<p>Poor response, especially if the shunt</p>
<p>is 30% or more.</p>
</td>
                <td style="width: 141px; height: 35px;" rowspan="1" colspan="1">
<p>ARDS, pneumonia</p>
</td>
              </tr>
              <tr style="height: 35px;">
                <td style="width: 102px; height: 35px;" rowspan="1" colspan="1">
<p>4.&#x000a0; Diffusion</p>
</td>
                <td style="width: 175px; height: 35px;" rowspan="1" colspan="1">
<p>Thickened alveolar membrane</p>
</td>
                <td style="width: 84.5486px; height: 35px;" rowspan="1" colspan="1">
<p>Elevated</p>
</td>
                <td style="width: 390.451px; height: 35px;" rowspan="1" colspan="1">
<p>&#x000a0;Good</p>
</td>
                <td style="width: 141px; height: 35px;" rowspan="1" colspan="1">
<p>Interstitial Lung Disease</p>
</td>
              </tr>
              <tr style="height: 35px;">
                <td style="width: 102px; height: 35px;" rowspan="1" colspan="1">
<p>5. High Altitude</p>
</td>
                <td style="width: 175px; height: 35px;" rowspan="1" colspan="1">
<p>Greater than&#x000a0;2,000 meters</p>
</td>
                <td style="width: 84.5486px; height: 35px;" rowspan="1" colspan="1">
<p>Normal</p>
</td>
                <td style="width: 390.451px; height: 35px;" rowspan="1" colspan="1">
<p>&#x000a0;Good</p>
</td>
                <td style="width: 141px; height: 35px;" rowspan="1" colspan="1">
<p>Acute mountain sickness.</p>
</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p>All but a high right-to-left shunt respond well to oxygen. In addition, if there is a shunt with relative hypoxemia, increasing oxygen to the area can increase oxygen carrying capacity of blood that&#x000a0;passes it. A shunt will not respond at all to oxygen, only when ventilation is close to zero or zero.</p>
        <p>&#x000a0; &#x000a0;3. V/Q abnormality</p>
        <p>The most common abnormality seen overall and in obstructive lung diseases. The most important point is that, in general, high V/Q areas (V/Q as high as 3) cannot make up for low V/Q areas.<xref ref-type="bibr" rid="article-154399.r34">[34]</xref>&#x000a0;High V/Q areas already carry as much oxygen as possible. The difference must come from low V/Q areas. Low V/Q areas like the base of the lung (V/Q less than 0.7) in upright humans do not make up the difference, which is where the problem lies. Here, high V/Q areas cannot respond to any more oxygen, and low V/Q areas tend to respond less to oxygen. Overall, these diseases respond well to oxygen.</p>
        <p>&#x000a0;&#x000a0;4. Hypoventilation</p>
        <p>Hypoventilation presents with&#x000a0;an elevated arterial PaC0<sub>2</sub> and a normal A-a gradient that responds well to oxygen. Neurologic disease and drug overdoses are two common causes.&#x000a0;</p>
        <p>&#x000a0; &#x000a0;5. Altitude</p>
        <p>Both barometric pressure and the A-a gradient&#x000a0;decrease with an increase in altitude. Therefore, there will be no negative effect with increasing elevation. Increasing altitude responds well to oxygen. High altitude is the rare 5th leading cause of hypoxemia.&#x000a0; &#x000a0; &#x000a0;</p>
        <p>Generally, the alveolar oxygen stays constant at about 100 mm Hg, and the arterial oxygen starts at about 95 mm Hg or less and goes down with age (time). This reduction is partly due to normal shunting and to a slight reduction in the A-a gradient that occurs when standing upright since the normal V/Q ratio is about 0.80 and not one. These are at least two reasons why the A-a gradient can never be zero.</p>
        <p>
<bold>Carbon Monoxide (CO) Poisoning </bold>
</p>
        <p>CO poisoning is one of the most common dyshemoglobinemia that can cause errors in conventional pulse oximetry using two-wavelength techniques. In CO intoxication, the pulse oximeter Sp0<sub>2</sub> is within normal limits, but the actual saturation of oxygenated hemoglobin is much lower.<xref ref-type="bibr" rid="article-154399.r32">[32]</xref>&#x000a0;Due to the high&#x000a0; CO affinity to hemoglobin than oxygen (200 times more affinity), there is a much lower level of&#x000a0;oxyhemoglobin. In addition, CO absorbs as much light as oxyhemoglobin (0<sub>2</sub>Hb) at 660 nm. This means that carboxyhemoglobin can falsely elevate the Sp0<sub>2</sub> measurements.<xref ref-type="bibr" rid="article-154399.r15">[15]</xref>&#x000a0;</p>
        <p>Therefore, with CO poisoning the pulse oximeter saturation is elevated to normal due to the elevated CO binding to hemoglobin and not due to oxygen binding to hemoglobin. Therefore not measuring the carboxyhemoglobin level makes the diagnosis of CO poisoning challenging and requires a high level of suspicion, especially&#x000a0;since&#x000a0;the symptoms are vague and the saturation levels on the pulse oximeter seem normal.&#x000a0;&#x000a0;</p>
        <p>
<bold>Evaluation with Co-oximetry</bold>
</p>
        <p>A complete work-up is necessary, including electrolytes, blood count, BUN, creatinine, urine toxicology and urinalysis, troponin, and electrocardiogram (ECG). A prolonged Q-T interval or ischemia is sometimes seen on the ECG. A chest radiograph and brain CT should also be done since sometimes the globus pallidus or other areas of the brain can be affected. An ABG with co-oximetry needs to be done on an arterial or venous blood sample to make the diagnosis. Arterial ABGs give more information about low oxygen in the blood with CO poisoning.<xref ref-type="bibr" rid="article-154399.r37">[37]</xref></p>
        <p>
<bold>Hyperbaric Oxygen Therapy</bold>
</p>
        <p>If indicated, co-oximetry can be considered. Overall, mortality with hyperbaric oxygen has been equivocal. Late neurologic findings are common. In one well-done randomized controlled trial, the result shows that three hyperbaric oxygen treatments done within 24 hours reduce cognitive sequelae at 6 and 12 months.<xref ref-type="bibr" rid="article-154399.r38">[38]</xref>&#x000a0;This suggests that at least neurologic damage can be minimized with hyperbaric oxygen treatment in some cases.</p>
      </sec>
      <sec id="article-154399.s6" sec-type="Other Issues">
        <title>Other Issues</title>
        <p>Detecting CO poisoning is&#x000a0;challenging without a high index of suspicion because the symptoms are so nonspecific.<xref ref-type="bibr" rid="article-154399.r39">[39]</xref></p>
        <p>Signs and symptoms of CO poisoning can include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Headache</p>
          </list-item>
          <list-item>
            <p>Dizziness</p>
          </list-item>
          <list-item>
            <p>Weakness</p>
          </list-item>
          <list-item>
            <p>Nausea and vomiting</p>
          </list-item>
          <list-item>
            <p>Shortness of breath</p>
          </list-item>
          <list-item>
            <p>Confusion</p>
          </list-item>
          <list-item>
            <p>Blurred vision</p>
          </list-item>
          <list-item>
            <p>Loss of consciousness</p>
          </list-item>
        </list>
        <p>CO poisoning can be dangerous for people who are intoxicated or sleeping&#x000a0;and can be lethal.&#x000a0;</p>
        <p>Studies have shown that pulse oximeters may underestimate saturation in individuals with dark skin.<xref ref-type="bibr" rid="article-154399.r27">[27]</xref><xref ref-type="bibr" rid="article-154399.r40">[40]</xref>&#x000a0;Due to this racial disparity in pulse oximetry technology, validation of the accuracy of these devices should be mandated by regulatory agencies, and caution is recommended in this group of patients who may be encountering hypoxia during their critical illness.<xref ref-type="bibr" rid="article-154399.r41">[41]</xref>&#x000a0;</p>
        <p>Pseudohypoxia: This condition is commonly seen as a complication of hyperglycemia due to uncontrolled diabetes.<xref ref-type="bibr" rid="article-154399.r42">[42]</xref>&#x000a0;The uncontrolled hyperglycemia can lead to overproduction of NADH and lower nicotinamide adenine dinucleotide (NAD), causing redox imbalance and cellular pseudohypoxia.<xref ref-type="bibr" rid="article-154399.r43">[43]</xref>&#x000a0;Pseudohypoxemia, however, is a reduction of oxygen in blood in vitro reported in hematological malignancy, such as in a patient with chronic lymphocytic leukemia.<xref ref-type="bibr" rid="article-154399.r44">[44]</xref></p>
      </sec>
      <sec id="article-154399.s7" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Pulmonary, critical care, anesthesiologist, and respiratory therapists&#x000a0;should possess a certain level of understanding regarding the A-a gradient, including its calculation and the potential implications of its levels (normal, low, or elevated).<xref ref-type="bibr" rid="article-154399.r3">[3]</xref><xref ref-type="bibr" rid="article-154399.r34">[34]</xref>&#x000a0;[Level 4] Additionally, supplemental oxygen should be administered conservatively (to maintain the Sp0<sub>2</sub> range&#x000a0;between 94-96%) to avoid increased mortality and adverse outcomes.<xref ref-type="bibr" rid="article-154399.r19">[19]</xref></p>
        <p>Pulse oximeters are readily available in different clinical settings. All healthcare workers, including physicians, mid-level practitioners, and nurses, should learn to use these devices and&#x000a0;interpret the information they provide.<xref ref-type="bibr" rid="article-154399.r32">[32]</xref>&#x000a0;[Level 5]</p>
        <p>Race correction for dark skin should be a factor, particularly in intensive care units.<xref ref-type="bibr" rid="article-154399.r27">[27]</xref><xref ref-type="bibr" rid="article-154399.r40">[40]</xref>&#x000a0;[Level 5] This includes knowing how co-oximetry might be helpful and&#x000a0;understanding dyshemoglobinemia. Carbon monoxide poisoning is the most common dyshemoglobinemia that healthcare workers can encounter. Carbon monoxide poisoning may or may not be recognized and sometimes causes neurologic&#x000a0;symptoms when diagnosed.<xref ref-type="bibr" rid="article-154399.r39">[39]</xref><xref ref-type="bibr" rid="article-154399.r38">[38]</xref>&#x000a0;[Level 1]</p>
      </sec>
      <sec id="article-154399.s8">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=154399&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=154399">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/154399/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=154399">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-154399.s9">
        <title>References</title>
        <ref id="article-154399.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jubran</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Pulse oximetry.</article-title>
            <source>Crit Care</source>
            <year>1999</year>
            <volume>3</volume>
            <issue>2</issue>
            <fpage>R11</fpage>
            <page-range>R11-R17</page-range>
            <pub-id pub-id-type="pmid">11094477</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154399.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ochs</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nyengaard</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Jung</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Knudsen</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Voigt</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wahlers</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Richter</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Gundersen</surname>
                <given-names>HJ</given-names>
              </name>
            </person-group>
            <article-title>The number of alveoli in the human lung.</article-title>
            <source>Am J Respir Crit Care Med</source>
            <year>2004</year>
            <month>Jan</month>
            <day>01</day>
            <volume>169</volume>
            <issue>1</issue>
            <fpage>120</fpage>
            <page-range>120-4</page-range>
            <pub-id pub-id-type="pmid">14512270</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154399.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Singh</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Soni</surname>
                <given-names>KD</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Aggarwal</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Venkateswaran</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Ashar</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Trikha</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Alveolar Arterial Gradient and Respiratory Index in Predicting the Outcome of COVID-19 Patients; a Retrospective Cross-Sectional Study.</article-title>
            <source>Arch Acad Emerg Med</source>
            <year>2022</year>
            <volume>10</volume>
            <issue>1</issue>
            <fpage>e28</fpage>
            <pub-id pub-id-type="pmid">35573712</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154399.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kronenberg</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Drage</surname>
                <given-names>CW</given-names>
              </name>
            </person-group>
            <article-title>Attenuation of the ventilatory and heart rate responses to hypoxia and hypercapnia with aging in normal men.</article-title>
            <source>J Clin Invest</source>
            <year>1973</year>
            <month>Aug</month>
            <volume>52</volume>
            <issue>8</issue>
            <fpage>1812</fpage>
            <page-range>1812-9</page-range>
            <pub-id pub-id-type="pmid">4719663</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154399.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thomas</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>van Diepen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Beekman</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sinha</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Brusca</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Alviar</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Jentzer</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bohula</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Katz</surname>
                <given-names>JN</given-names>
              </name>
              <name>
                <surname>Shahu</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Barnett</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Morrow</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Gilmore</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Solomon</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>PE</given-names>
              </name>
            </person-group>
            <article-title>Oxygen Supplementation and Hyperoxia in Critically Ill Cardiac Patients: From Pathophysiology to Clinical Practice.</article-title>
            <source>JACC Adv</source>
            <year>2022</year>
            <month>Aug</month>
            <volume>1</volume>
            <issue>3</issue>
            <pub-id pub-id-type="pmid">36238193</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154399.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hofmann</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>James</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Jernberg</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Lindahl</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Erlinge</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Witt</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Arefalk</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Frick</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Alfredsson</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Nilsson</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Ravn-Fischer</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Omerovic</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Kellerth</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Sparv</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Ekelund</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Linder</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ekstr&#x000f6;m</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lauermann</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Haaga</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Pernow</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>&#x000d6;stlund</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Herlitz</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Svensson</surname>
                <given-names>L</given-names>
              </name>
              <collab>DETO2X&#x02013;SWEDEHEART Investigators</collab>
            </person-group>
            <article-title>Oxygen Therapy in Suspected Acute Myocardial Infarction.</article-title>
            <source>N Engl J Med</source>
            <year>2017</year>
            <month>Sep</month>
            <day>28</day>
            <volume>377</volume>
            <issue>13</issue>
            <fpage>1240</fpage>
            <page-range>1240-1249</page-range>
            <pub-id pub-id-type="pmid">28844200</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154399.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Loscalzo</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Is Oxygen Therapy Beneficial in Acute Myocardial Infarction? Simple Question, Complicated Mechanism, Simple Answer.</article-title>
            <source>N Engl J Med</source>
            <year>2017</year>
            <month>Sep</month>
            <day>28</day>
            <volume>377</volume>
            <issue>13</issue>
            <fpage>1286</fpage>
            <page-range>1286-1287</page-range>
            <pub-id pub-id-type="pmid">28844195</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154399.r8">
          <label>8</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Bhutta</surname>
                <given-names>BS</given-names>
              </name>
              <name>
                <surname>Alghoula</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Berim</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <chapter-title>Hypoxia</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2024</year>
            <month>3</month>
            <day>4</day>
            <pub-id pub-id-type="pmid">29493941</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154399.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>MacIntyre</surname>
                <given-names>NR</given-names>
              </name>
            </person-group>
            <article-title>Tissue hypoxia: implications for the respiratory clinician.</article-title>
            <source>Respir Care</source>
            <year>2014</year>
            <month>Oct</month>
            <volume>59</volume>
            <issue>10</issue>
            <fpage>1590</fpage>
            <page-range>1590-6</page-range>
            <pub-id pub-id-type="pmid">25161296</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154399.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Luks</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Swenson</surname>
                <given-names>ER</given-names>
              </name>
            </person-group>
            <article-title>Pulse Oximetry for Monitoring Patients with COVID-19 at Home. Potential Pitfalls and Practical Guidance.</article-title>
            <source>Ann Am Thorac Soc</source>
            <year>2020</year>
            <month>Sep</month>
            <volume>17</volume>
            <issue>9</issue>
            <fpage>1040</fpage>
            <page-range>1040-1046</page-range>
            <pub-id pub-id-type="pmid">32521167</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154399.r11">
          <label>11</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Graham</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Traylor</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <chapter-title>Cyanide Toxicity</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>2</month>
            <day>13</day>
            <pub-id pub-id-type="pmid">29939573</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154399.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Weingarten</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Neuman</surname>
                <given-names>GG</given-names>
              </name>
              <name>
                <surname>Segal</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Kushins</surname>
                <given-names>LG</given-names>
              </name>
              <name>
                <surname>Fermon</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Pulse oximetry to determine oxygenation in a patient with pseudohypoxemia.</article-title>
            <source>Anesth Analg</source>
            <year>1988</year>
            <month>Jul</month>
            <volume>67</volume>
            <issue>7</issue>
            <fpage>711</fpage>
            <page-range>711-2</page-range>
            <pub-id pub-id-type="pmid">3382048</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154399.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alves Barbosa</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Guimar&#x000e3;es Andrade</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>de Almeida Sousa</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Correia</surname>
                <given-names>JW</given-names>
              </name>
            </person-group>
            <article-title>COVID-19 in a Patient with Chronic Lymphocytic Leukaemia with Pseudohypoxemia.</article-title>
            <source>Eur J Case Rep Intern Med</source>
            <year>2020</year>
            <volume>7</volume>
            <issue>7</issue>
            <fpage>001763</fpage>
            <pub-id pub-id-type="pmid">32665936</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154399.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Skold</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cosco</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Klein</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Methemoglobinemia: pathogenesis, diagnosis, and management.</article-title>
            <source>South Med J</source>
            <year>2011</year>
            <month>Nov</month>
            <volume>104</volume>
            <issue>11</issue>
            <fpage>757</fpage>
            <page-range>757-61</page-range>
            <pub-id pub-id-type="pmid">22024786</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154399.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Barker</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Curry</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Redford</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Morgan</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Measurement of carboxyhemoglobin and methemoglobin by pulse oximetry: a human volunteer study.</article-title>
            <source>Anesthesiology</source>
            <year>2006</year>
            <month>Nov</month>
            <volume>105</volume>
            <issue>5</issue>
            <fpage>892</fpage>
            <page-range>892-7</page-range>
            <pub-id pub-id-type="pmid">17065881</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154399.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Eisenkraft</surname>
                <given-names>JB</given-names>
              </name>
            </person-group>
            <article-title>Pulse oximeter desaturation due to methemoglobinemia.</article-title>
            <source>Anesthesiology</source>
            <year>1988</year>
            <month>Feb</month>
            <volume>68</volume>
            <issue>2</issue>
            <fpage>279</fpage>
            <page-range>279-82</page-range>
            <pub-id pub-id-type="pmid">3341583</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154399.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>George</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Goetz</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>A case of sulfhemoglobinemia in a child with chronic constipation.</article-title>
            <source>Respir Med Case Rep</source>
            <year>2017</year>
            <volume>21</volume>
            <fpage>21</fpage>
            <page-range>21-24</page-range>
            <pub-id pub-id-type="pmid">28348950</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154399.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Singer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Young</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Laffey</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Asfar</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Taccone</surname>
                <given-names>FS</given-names>
              </name>
              <name>
                <surname>Skrifvars</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Meyhoff</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Radermacher</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Dangers of hyperoxia.</article-title>
            <source>Crit Care</source>
            <year>2021</year>
            <month>Dec</month>
            <day>19</day>
            <volume>25</volume>
            <issue>1</issue>
            <fpage>440</fpage>
            <pub-id pub-id-type="pmid">34924022</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154399.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chu</surname>
                <given-names>DK</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>LH</given-names>
              </name>
              <name>
                <surname>Young</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Zamiri</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Almenawer</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Jaeschke</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Szczeklik</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Sch&#x000fc;nemann</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Neary</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Alhazzani</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Mortality and morbidity in acutely ill adults treated with liberal versus conservative oxygen therapy (IOTA): a systematic review and meta-analysis.</article-title>
            <source>Lancet</source>
            <year>2018</year>
            <month>Apr</month>
            <day>28</day>
            <volume>391</volume>
            <issue>10131</issue>
            <fpage>1693</fpage>
            <page-range>1693-1705</page-range>
            <pub-id pub-id-type="pmid">29726345</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154399.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Girardis</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Busani</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Damiani</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Donati</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rinaldi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Marudi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Morelli</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Antonelli</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Singer</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Effect of Conservative vs Conventional Oxygen Therapy on Mortality Among Patients in an Intensive Care Unit: The Oxygen-ICU Randomized Clinical Trial.</article-title>
            <source>JAMA</source>
            <year>2016</year>
            <month>Oct</month>
            <day>18</day>
            <volume>316</volume>
            <issue>15</issue>
            <fpage>1583</fpage>
            <page-range>1583-1589</page-range>
            <pub-id pub-id-type="pmid">27706466</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154399.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aggarwal</surname>
                <given-names>NR</given-names>
              </name>
              <name>
                <surname>Brower</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Hager</surname>
                <given-names>DN</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>BT</given-names>
              </name>
              <name>
                <surname>Netzer</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Shanholtz</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lagakos</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Checkley</surname>
                <given-names>W</given-names>
              </name>
              <collab>National Institutes of Health Acute Respiratory Distress Syndrome Network Investigators</collab>
            </person-group>
            <article-title>Oxygen Exposure Resulting in Arterial Oxygen Tensions Above the Protocol Goal Was Associated With Worse Clinical Outcomes in Acute Respiratory Distress Syndrome.</article-title>
            <source>Crit Care Med</source>
            <year>2018</year>
            <month>Apr</month>
            <volume>46</volume>
            <issue>4</issue>
            <fpage>517</fpage>
            <page-range>517-524</page-range>
            <pub-id pub-id-type="pmid">29261565</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154399.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jacobs</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Lederer</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Garvey</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Hernandez</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lindell</surname>
                <given-names>KO</given-names>
              </name>
              <name>
                <surname>McLaughlin</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Schneidman</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Casaburi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Cosgrove</surname>
                <given-names>GP</given-names>
              </name>
              <name>
                <surname>Devitt</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Erickson</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Ewart</surname>
                <given-names>GW</given-names>
              </name>
              <name>
                <surname>Giordano</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Harbaugh</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kallstrom</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Kroner</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Krishnan</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Lamberti</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Porte</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Prieto-Centurion</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Sherman</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Sullivan</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Sward</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Swigris</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Upson</surname>
                <given-names>DJ</given-names>
              </name>
            </person-group>
            <article-title>Optimizing Home Oxygen Therapy. An Official American Thoracic Society Workshop Report.</article-title>
            <source>Ann Am Thorac Soc</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>15</volume>
            <issue>12</issue>
            <fpage>1369</fpage>
            <page-range>1369-1381</page-range>
            <pub-id pub-id-type="pmid">30499721</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154399.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <collab>Long-Term Oxygen Treatment Trial Research Group</collab>
              <name>
                <surname>Albert</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Au</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Blackford</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Casaburi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Cooper</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Criner</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Diaz</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Fuhlbrigge</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Gay</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Kanner</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>MacIntyre</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Martinez</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>Panos</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Piantadosi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sciurba</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Shade</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Stibolt</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Stoller</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Wise</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Yusen</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Tonascia</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sternberg</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Bailey</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>A Randomized Trial of Long-Term Oxygen for COPD with Moderate Desaturation.</article-title>
            <source>N Engl J Med</source>
            <year>2016</year>
            <month>Oct</month>
            <day>27</day>
            <volume>375</volume>
            <issue>17</issue>
            <fpage>1617</fpage>
            <page-range>1617-1627</page-range>
            <pub-id pub-id-type="pmid">27783918</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154399.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sj&#x000f6;dahl Matsson</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Ekstr&#x000f6;m</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Peripheral Oxygen Saturation Misclassifies Hypoxemia.</article-title>
            <source>Ann Am Thorac Soc</source>
            <year>2023</year>
            <month>Jul</month>
            <volume>20</volume>
            <issue>7</issue>
            <fpage>1070</fpage>
            <page-range>1070-1073</page-range>
            <pub-id pub-id-type="pmid">37083544</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154399.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bangash</surname>
                <given-names>MN</given-names>
              </name>
              <name>
                <surname>Hodson</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Evison</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Johnston</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Gallier</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sapey</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Parekh</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Impact of ethnicity on the accuracy of measurements of oxygen saturations: A retrospective observational cohort study.</article-title>
            <source>EClinicalMedicine</source>
            <year>2022</year>
            <month>Jun</month>
            <volume>48</volume>
            <fpage>101428</fpage>
            <pub-id pub-id-type="pmid">35706489</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154399.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lacasse</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Th&#x000e9;riault</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>St-Pierre</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Bernard</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>S&#x000e9;ri&#x000e8;s</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Bernatchez</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Maltais</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Oximetry neither to prescribe long-term oxygen therapy nor to screen for severe hypoxaemia.</article-title>
            <source>ERJ Open Res</source>
            <year>2021</year>
            <month>Oct</month>
            <volume>7</volume>
            <issue>4</issue>
            <pub-id pub-id-type="pmid">34671670</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154399.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tobin</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Jubran</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Pulse oximetry, racial bias and statistical bias.</article-title>
            <source>Ann Intensive Care</source>
            <year>2022</year>
            <month>Jan</month>
            <day>04</day>
            <volume>12</volume>
            <issue>1</issue>
            <fpage>2</fpage>
            <pub-id pub-id-type="pmid">34981267</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154399.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bickler</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Tremper</surname>
                <given-names>KK</given-names>
              </name>
            </person-group>
            <article-title>The Pulse Oximeter Is Amazing, but Not Perfect.</article-title>
            <source>Anesthesiology</source>
            <year>2022</year>
            <month>May</month>
            <day>01</day>
            <volume>136</volume>
            <issue>5</issue>
            <fpage>670</fpage>
            <page-range>670-671</page-range>
            <pub-id pub-id-type="pmid">35303063</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154399.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moller</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Johannessen</surname>
                <given-names>NW</given-names>
              </name>
              <name>
                <surname>Espersen</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ravlo</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Pedersen</surname>
                <given-names>BD</given-names>
              </name>
              <name>
                <surname>Jensen</surname>
                <given-names>PF</given-names>
              </name>
              <name>
                <surname>Rasmussen</surname>
                <given-names>NH</given-names>
              </name>
              <name>
                <surname>Rasmussen</surname>
                <given-names>LS</given-names>
              </name>
              <name>
                <surname>Pedersen</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Cooper</surname>
                <given-names>JB</given-names>
              </name>
            </person-group>
            <article-title>Randomized evaluation of pulse oximetry in 20,802 patients: II. Perioperative events and postoperative complications.</article-title>
            <source>Anesthesiology</source>
            <year>1993</year>
            <month>Mar</month>
            <volume>78</volume>
            <issue>3</issue>
            <fpage>445</fpage>
            <page-range>445-53</page-range>
            <pub-id pub-id-type="pmid">8457045</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154399.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gallagher</surname>
                <given-names>SF</given-names>
              </name>
              <name>
                <surname>Haines</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Osterlund</surname>
                <given-names>LG</given-names>
              </name>
              <name>
                <surname>Mullen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Downs</surname>
                <given-names>JB</given-names>
              </name>
            </person-group>
            <article-title>Postoperative hypoxemia: common, undetected, and unsuspected after bariatric surgery.</article-title>
            <source>J Surg Res</source>
            <year>2010</year>
            <month>Apr</month>
            <volume>159</volume>
            <issue>2</issue>
            <fpage>622</fpage>
            <page-range>622-6</page-range>
            <pub-id pub-id-type="pmid">20006346</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154399.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tobin</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Laghi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Jubran</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Why COVID-19 Silent Hypoxemia Is Baffling to Physicians.</article-title>
            <source>Am J Respir Crit Care Med</source>
            <year>2020</year>
            <month>Aug</month>
            <day>01</day>
            <volume>202</volume>
            <issue>3</issue>
            <fpage>356</fpage>
            <page-range>356-360</page-range>
            <pub-id pub-id-type="pmid">32539537</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154399.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tremper</surname>
                <given-names>KK</given-names>
              </name>
              <name>
                <surname>Barker</surname>
                <given-names>SJ</given-names>
              </name>
            </person-group>
            <article-title>Pulse oximetry.</article-title>
            <source>Anesthesiology</source>
            <year>1989</year>
            <month>Jan</month>
            <volume>70</volume>
            <issue>1</issue>
            <fpage>98</fpage>
            <page-range>98-108</page-range>
            <pub-id pub-id-type="pmid">2643368</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154399.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Barker</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Badal</surname>
                <given-names>JJ</given-names>
              </name>
            </person-group>
            <article-title>The measurement of dyshemoglobins and total hemoglobin by pulse oximetry.</article-title>
            <source>Curr Opin Anaesthesiol</source>
            <year>2008</year>
            <month>Dec</month>
            <volume>21</volume>
            <issue>6</issue>
            <fpage>805</fpage>
            <page-range>805-10</page-range>
            <pub-id pub-id-type="pmid">18997533</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154399.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sarkar</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Niranjan</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Banyal</surname>
                <given-names>PK</given-names>
              </name>
            </person-group>
            <article-title>Mechanisms of hypoxemia.</article-title>
            <source>Lung India</source>
            <year>2017</year>
            <season>Jan-Feb</season>
            <volume>34</volume>
            <issue>1</issue>
            <fpage>47</fpage>
            <page-range>47-60</page-range>
            <pub-id pub-id-type="pmid">28144061</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154399.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Macintyre</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Crapo</surname>
                <given-names>RO</given-names>
              </name>
              <name>
                <surname>Viegi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>van der Grinten</surname>
                <given-names>CP</given-names>
              </name>
              <name>
                <surname>Brusasco</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Burgos</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Casaburi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Coates</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Enright</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Gustafsson</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Hankinson</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Jensen</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>McKay</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Navajas</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Pedersen</surname>
                <given-names>OF</given-names>
              </name>
              <name>
                <surname>Pellegrino</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Wanger</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Standardisation of the single-breath determination of carbon monoxide uptake in the lung.</article-title>
            <source>Eur Respir J</source>
            <year>2005</year>
            <month>Oct</month>
            <volume>26</volume>
            <issue>4</issue>
            <fpage>720</fpage>
            <page-range>720-35</page-range>
            <pub-id pub-id-type="pmid">16204605</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154399.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Graham</surname>
                <given-names>BL</given-names>
              </name>
              <name>
                <surname>Brusasco</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Burgos</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Cooper</surname>
                <given-names>BG</given-names>
              </name>
              <name>
                <surname>Jensen</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kendrick</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>MacIntyre</surname>
                <given-names>NR</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>BR</given-names>
              </name>
              <name>
                <surname>Wanger</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Executive Summary: 2017 ERS/ATS standards for single-breath carbon monoxide uptake&#x000a0;in&#x000a0;the lung.</article-title>
            <source>Eur Respir J</source>
            <year>2017</year>
            <month>Jan</month>
            <volume>49</volume>
            <issue>1</issue>
            <pub-id pub-id-type="pmid">28049167</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154399.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hampson</surname>
                <given-names>NB</given-names>
              </name>
            </person-group>
            <article-title>Pulse oximetry in severe carbon monoxide poisoning.</article-title>
            <source>Chest</source>
            <year>1998</year>
            <month>Oct</month>
            <volume>114</volume>
            <issue>4</issue>
            <fpage>1036</fpage>
            <page-range>1036-41</page-range>
            <pub-id pub-id-type="pmid">9792574</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154399.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Weaver</surname>
                <given-names>LK</given-names>
              </name>
              <name>
                <surname>Hopkins</surname>
                <given-names>RO</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Churchill</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Elliott</surname>
                <given-names>CG</given-names>
              </name>
              <name>
                <surname>Clemmer</surname>
                <given-names>TP</given-names>
              </name>
              <name>
                <surname>Orme</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>FO</given-names>
              </name>
              <name>
                <surname>Morris</surname>
                <given-names>AH</given-names>
              </name>
            </person-group>
            <article-title>Hyperbaric oxygen for acute carbon monoxide poisoning.</article-title>
            <source>N Engl J Med</source>
            <year>2002</year>
            <month>Oct</month>
            <day>03</day>
            <volume>347</volume>
            <issue>14</issue>
            <fpage>1057</fpage>
            <page-range>1057-67</page-range>
            <pub-id pub-id-type="pmid">12362006</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154399.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mattiuzzi</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lippi</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Worldwide epidemiology of carbon monoxide poisoning.</article-title>
            <source>Hum Exp Toxicol</source>
            <year>2020</year>
            <month>Apr</month>
            <volume>39</volume>
            <issue>4</issue>
            <fpage>387</fpage>
            <page-range>387-392</page-range>
            <pub-id pub-id-type="pmid">31789062</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154399.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vyas</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Eisenstein</surname>
                <given-names>LG</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>DS</given-names>
              </name>
            </person-group>
            <article-title>Hidden in Plain Sight - Reconsidering the Use of Race Correction in Clinical Algorithms.</article-title>
            <source>N Engl J Med</source>
            <year>2020</year>
            <month>Aug</month>
            <day>27</day>
            <volume>383</volume>
            <issue>9</issue>
            <fpage>874</fpage>
            <page-range>874-882</page-range>
            <pub-id pub-id-type="pmid">32853499</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154399.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sudat</surname>
                <given-names>SEK</given-names>
              </name>
              <name>
                <surname>Wesson</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Rhoads</surname>
                <given-names>KF</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Aboelata</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Pressman</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Mani</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Azar</surname>
                <given-names>KMJ</given-names>
              </name>
            </person-group>
            <article-title>Racial Disparities in Pulse Oximeter Device Inaccuracy and Estimated Clinical Impact on COVID-19 Treatment Course.</article-title>
            <source>Am J Epidemiol</source>
            <year>2023</year>
            <month>May</month>
            <day>05</day>
            <volume>192</volume>
            <issue>5</issue>
            <fpage>703</fpage>
            <page-range>703-713</page-range>
            <pub-id pub-id-type="pmid">36173743</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154399.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Williamson</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Frangos</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hasan</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>Ido</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kawamura</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Nyengaard</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>van den Enden</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kilo</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Tilton</surname>
                <given-names>RG</given-names>
              </name>
            </person-group>
            <article-title>Hyperglycemic pseudohypoxia and diabetic complications.</article-title>
            <source>Diabetes</source>
            <year>1993</year>
            <month>Jun</month>
            <volume>42</volume>
            <issue>6</issue>
            <fpage>801</fpage>
            <page-range>801-13</page-range>
            <pub-id pub-id-type="pmid">8495803</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154399.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Song</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Yan</surname>
                <given-names>LJ</given-names>
              </name>
            </person-group>
            <article-title>Role of pseudohypoxia in the pathogenesis of type 2 diabetes.</article-title>
            <source>Hypoxia (Auckl)</source>
            <year>2019</year>
            <volume>7</volume>
            <fpage>33</fpage>
            <page-range>33-40</page-range>
            <pub-id pub-id-type="pmid">31240235</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154399.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hess</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Nichols</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Hunt</surname>
                <given-names>WB</given-names>
              </name>
              <name>
                <surname>Suratt</surname>
                <given-names>PM</given-names>
              </name>
            </person-group>
            <article-title>Pseudohypoxemia secondary to leukemia and thrombocytosis.</article-title>
            <source>N Engl J Med</source>
            <year>1979</year>
            <month>Aug</month>
            <day>16</day>
            <volume>301</volume>
            <issue>7</issue>
            <fpage>361</fpage>
            <page-range>361-3</page-range>
            <pub-id pub-id-type="pmid">460325</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
